Cognitive Effects of Citicoline on Attention in Healthy Mean and Women
Completed · Not applicable · Has a placebo group
Conditions studied: Healthy
In brief
The objective of this trial is to determine the effects of citicoline on cognitive performance for attention in healrhy Men and Women compared to a placebo.
Key facts
- Study ID
- NCT04967157
- Run by
- Kirin Holdings Company, Limited
- People needed
- 148
- Starts
- 2021-09-08
- Expected to finish
- 2022-08-31
- Last updated by the study team
- 2025-04-06
Who can join
Age: 35 and older, up to 75. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- male or female, 35-75 years of age
- Scores ≥ 24 on the MMSE, ≤15 on the CESD-R, and scores below the population median (i.e., below 81.25, above 36.8) on the Gradual CPT
- Self-reported poor attention
- no health conditions that would prevent him or her from fulfilling the study requirements on the basis of medical history and routine laboratory test results
- Understands the study procedures and signs forms providing informed consent to participate in the study and authorizes the release of relevant protected health information to the Principal Investigator.
You may not qualify if…
- color blindness
- Known allergy or sensitivity to any of the ingredients in the study products and/or any ingredients of the breakfast meal provided
- major medical or neurological illness
- diagnosis of attention deficit hyperactive disorder (ADHD)
- female who is pregnant, planning to be pregnant during the study period
- requiring treatment with a drug which might obscure the action of the study treatment
Where it is running
- Biofortis Clinical Research, Inc. — Addison, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.